Schizophrenia improved by mental and physical exercise

Scientists at Melbourne's Howard Florey Institute have shown that mental and physical exercise can improve behavioural deficits in schizophrenia and repair damaged chemical transmitter pathways in the brain.

Dr Anthony Hannan, along with Dr Caitlin McOmish, Emma Burrows and colleagues, characterised a genetically altered mouse and discovered that it had schizophrenia-like behaviours, including learning and memory problems, the inability to process complex information, and abnormal responses to particular sensory stimuli.

The scientists found the mouse’s condition significantly improved by simply giving them enhanced mental and physical exercise – putting running wheels in their cages, plus interesting items to smell, see and touch.

Not only did the mouse’s schizophrenia-like symptoms ease through this environmental enrichment, but a specific chemical transmitter pathway found to be abnormal in the cerebral cortex of the mice was selectively rescued.

An anti-psychotic drug used by humans also improved the mouse’s condition, indicating that this mouse is a valid model for schizophrenia in humans.

Dr Hannan said this discovery could pave the way for the development of better treatments for schizophrenia.

“Through our research, and that of others, we hope a new class of therapeutic drugs will be developed that mimic the effects of environmental enrichment in the brain to treat various brain disorders, possibly including schizophrenia,” Dr Hannan said.

“Pharmaceutical approaches may not be the sole answer for a given brain disease. People may still need optimal levels of physical and mental activity, as well as a healthy diet, plus the right drugs.

“We have already identified specific molecules that could be targets for what I call ‘enviromimetics’ and these may have relevance for other brain diseases.

“However, there are obviously major differences between mice and men, and large-scale clinical trials are needed to identify the most beneficial drugs,“ he said.

Schizophrenia is a brain disorder that is brought on through a complex and largely unknown interaction of genes and environment.

There is a nature-nurture aspect to schizophrenia because in human identical twins, if one twin develops schizophrenia, there is only a 50% chance the other twin, who has identical genes, will develop the illness.

Dr Anthony Hannan's ground-breaking environmental enrichment studies have previously shown that a combination of mental and physical exercise could delay the onset and progression of Huntington’s disease. As well as movement problems (e.g. chorea) and cognitive deficits (culminating in dementia) this disease has psychiatric symptoms, which can include depression and psychosis.

At only 37 years of age, Dr Hannan is internationally recognised for his Huntington’s disease research and was awarded a $1 million Pfizer Australia Senior Research Fellowship to fund his ongoing environmental enrichment studies.

This research, which also involved collaboration with scientists from the Mental Health Research Institute of Victoria, is currently an advanced online publication of the international journal Molecular Psychiatry.

For information about schizophrenia, visit the Florey’s website.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Peter Falkai suggests promising new directions in schizophrenia treatment